MedPath

The evaluation of the efficacy of sitagliptin for NASH/NAFLD patients-a multicenter open-label study

Not Applicable
Recruiting
Conditions
nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Registration Number
JPRN-UMIN000005349
Lead Sponsor
Kyoto Prefectural University of Medicine, Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) drinkers (ethanol intake > 20g/day) 2) HBsAg and/or HCV Ab positive patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath